Search Results
Study of Carboplatin plus Nivolumab in Metastatic Triple-Negative Breast Cancer
Dr. Eric Winer on Carboplatin and/or Bevacizumab in Triple-Negative Breast Cancer
New Research in Metastatic Breast Cancer | SABCS 2019
Study of SACI-IO for Triple Negative Metastatic Breast Cancer
The IMpassion130 Study in Metastatic TNBC
Current treatment landscape of triple negative breast cancer
Systemic Therapy for Recurrent Metastatic TNBC
Dr. Rugo on the Results of the KEYNOTE-522 Trial in TNBC
Comparing 3 Types of Targeted Therapies for Triple-Negative Breast Cancer
SABCS 2013: Triple-Negative Therapy and Chemotherapy
Eribulin in Metastatic TNBC: Real-World Data
KEYNOTE-355: First-line pembrolizumab plus chemotherapy for metastatic triple-negative breast ca...
